NASDAQ : ENSC
Ensysce Biosciences, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 0.421 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 8.19M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Ensysce Biosciences, Inc. (ENSC) reported revenue of 4.50M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 4.50M | 5.07M | 5.21M | 2.23M | 2.52M | 3.53M |
| Cost of Revenue | 12.39M | 10.38M | 7.22M | 7.59M | 19.84M | 4.69M |
| Gross Profit | -7.89M | -5.31M | -2.01M | -5.36M | -17.31M | -1.16M |
| Selling, General & Admin | 4.78M | 4.93M | 4.72M | 5.36M | 6.91M | 18.71M |
| Operating Expenses | 4.78M | 4.93M | 4.72M | 5.36M | 6.91M | 18.71M |
| Operating Income | -12.66M | -10.24M | -6.73M | -10.72M | -24.22M | -19.87M |
| Interest Expense | -15.99K | -18.77K | -1.29M | -353.94K | -1.25M | -3.22M |
| Other Non Operating Income (Expenses) | 53.15K | 83.53K | 33.57K | 299.38K | -530.48K | -2.91M |
| EBT Excluding Unusual Items | -12.62M | -10.18M | -7.99M | -10.77M | -26.00M | -26.00M |
| Other Unusual Items | 146.48K | 1.79M | -3.15M | |||
| Pretax Income | -12.62M | -10.18M | -7.99M | -10.63M | -24.21M | -29.15M |
| Earnings From Continuing Operations | -12.62M | -10.18M | -7.99M | -10.63M | -24.21M | -29.15M |
| Minority Interest in Earnings | 487.00 | 487.00 | 74.00 | 13.20K | 35.39K | 62.19K |
| Net Income | -12.62M | -10.18M | -7.99M | -10.61M | -24.17M | -29.08M |
| Preferred Dividends & Other Adjustments | 290.00 | 12.94K | 913.20K | 803.14K | ||
| Net Income to Common | -12.62M | -10.18M | -7.99M | -10.63M | -25.09M | -29.89M |
| Shares Outstanding (Basic) | 6.63M | 2.56M | 697.69K | 150.94K | 11.99K | |
| Shares Outstanding (Diluted) | 6.63M | 2.56M | 697.69K | 150.94K | 11.99K | |
| EPS (Basic) | -1.90 | -3.98 | -11.45 | -70.40 | -2,091.33 | |
| EPS (Diluted) | -1.90 | -3.98 | -11.45 | -70.40 | -2,091.33 | |
| Free Cash Flow | -8.98M | -7.93M | -7.50M | -10.78M | -17.89M | -8.24M |
| Free Cash Flow Per Share | -1.35 | -3.10 | -10.75 | -71.42 | -1,491.24 | |
| Gross Margin | -175.21% | -104.81% | -38.57% | -240.17% | -32.82% | |
| Operating Margin | -281.32% | -202.13% | -129.18% | -480.52% | -959.91% | -562.71% |
| Profit Margin | -280.48% | -200.84% | -153.31% | -476.39% | -994.12% | -846.37% |
| Free Cash Flow Margin | -199.50% | -156.51% | -144.00% | -483.30% | -708.87% | -233.41% |
| EBITDA | -10.23M | -24.22M | -19.87M | |||
| EBITDA Margin | -202.00% | |||||
| D&A For EBITDA | 6.53K | 151.00 | 151.00 | |||
| EBIT | -12.66M | -10.24M | -6.73M | -10.72M | -24.22M | -19.87M |
| EBIT Margin | -281.32% | -202.12% | -129.18% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 676.70K | 4.31M | 3.50M | 1.12M | 3.15M | 12.26M |
| Cash & Short-Term Investments | 676.70K | 4.31M | 3.50M | 1.12M | 3.15M | 12.26M |
| Receivables | 416.81K | 420.35K | 124.11K | 97.56K | 276.82K | 441.72K |
| Prepaid Expenses | 441.35K | 405.69K | 358.03K | 514.23K | 547.01K | 807.41K |
| Other Current Assets | 1.31M | 2.11M | 1.36M | 553.47K | 1.33M | 2.15M |
| Total Current Assets | 2.85M | 7.24M | 5.34M | 2.29M | 5.30M | 15.66M |
| Property, Plant & Equipment | 111.06K | 124.13K | ||||
| Other Long-Term Assets | 85.88K | 252.55K | 419.22K | 585.88K | 754.76K | |
| Total Assets | 2.96M | 7.45M | 5.60M | 2.71M | 5.89M | 16.42M |
| Accounts Payable | 1.98M | 3.27M | 1.36M | 1.94M | 2.94M | 301.10K |
| Accrued Expenses | 1.89M | 993.41K | 548.46K | 542.26K | 2.23M | 3.41M |
| Short-Term Debt | 196.84K | 306.71K | 301.66K | 854.70K | 4.27M | |
| Current Portion of Long-Term Debt | 12.75M | |||||
| Current Portion of Leases | 27.32K | 24.87K | ||||
| Total Current Liabilities | 4.07M | 4.57M | 2.21M | 3.33M | 9.46M | 16.48M |
| Long-Term Debt | 140.15K | 4.44M | ||||
| Other Long-Term Liabilities | 10.10K | 26.39K | 310.35K | 3.65M | ||
| Total Liabilities | 4.07M | 4.57M | 2.22M | 3.36M | 9.91M | 24.58M |
| Common Stock | 1.62K | 459.00 | 136.00 | 21.00 | 53.00 | 124.00 |
| Additional Paid-In Capital | 145.06M | 142.93M | 133.25M | 121.23M | 107.22M | 77.97M |
| Retained Earnings | -145.85M | -139.72M | -129.54M | -121.56M | -110.93M | -85.85M |
| Total Common Equity | -781.70K | 3.21M | 3.71M | -322.86K | -3.71M | -7.88M |
| Minority Interest | -329.14K | -328.97K | -328.48K | -328.41K | -315.21K | -279.81K |
| Shareholders' Equity | -1.11M | 2.88M | 3.38M | -651.27K | -4.03M | -8.16M |
| Total Liabilities & Equity | 2.96M | 7.45M | 5.60M | 2.71M | 5.89M | 16.42M |
| Total Debt | 196.84K | 306.71K | 301.66K | 854.70K | 4.43M | 17.21M |
| Net Cash (Debt) | 479.86K | 4.00M | 3.20M | 268.91K | -1.29M | -4.95M |
| Net Cash Per Share | 0.07 | 1.57 | 4.59 | 1.78 | -107.24 | |
| Filing Date Shares Outstanding | 19.46M | 9.28M | 1.41M | 488.61K | 85.70K | 16.39K |
| Total Common Shares Outstanding | 16.23M | 4.57M | 1.36M | 209.74K | 35.63K | |
| Working Capital | -1.22M | 2.67M | 3.14M | -1.04M | -4.17M | -819.07K |
| Book Value Per Share | -0.05 | 0.70 | 2.74 | -1.54 | -104.24 | |
| Tangible Book Value | -781.70K | 3.21M | 3.71M | -322.86K | -3.71M | -7.88M |
| Tangible Book Value Per Share | -0.05 | 0.70 | 2.74 | -1.54 | -104.24 |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -12.62M | -10.18M | -7.99M | -10.61M | -24.17M | -29.08M |
| Depreciation & Amortization | 19.60K | 6.53K | 151.00 | |||
| Other Amortization | 1.20M | 326.15K | 946.09K | 1.92M | ||
| Loss (Gain) From Sale of Assets | -4.50K | |||||
| Stock-Based Compensation | 1.19M | 845.77K | 110.72K | 879.16K | 1.07M | 121.76K |
| Other Operating Activities | 8.18K | 1.81K | 27.56K | -425.14K | -1.21M | 20.10M |
| Change in Accounts Receivable | 788.17K | -296.23K | -26.55K | 179.26K | 164.90K | -441.72K |
| Change in Accounts Payable | 774.86K | 1.82M | -578.93K | -1.23M | 2.64M | -1.42M |
| Change in Other Net Operating Assets | 984.92K | -4.13K | -245.77K | 107.95K | 2.67M | 561.72K |
| Operating Cash Flow | -8.86M | -7.81M | -7.50M | -10.78M | -17.89M | -8.24M |
| Capital Expenditures | -123.64K | -123.64K | ||||
| Sale of Property, Plant & Equipment | 4.50K | |||||
| Investing Cash Flow | -123.64K | -123.64K | 4.50K | |||
| Long-Term Debt Issued | 1.61M | 7.53M | 14.38M | |||
| Total Debt Issued | 1.61M | 7.53M | 14.38M | |||
| Long-Term Debt Repaid | -216.28K | -857.72K | -1.45M | -2.00M | -956.32K | |
| Net Debt Issued (Repaid) | -208.94K | -216.28K | -857.72K | 153.76K | 5.53M | 13.42M |
| Issuance of Common Stock | 2.18M | 3.67M | 4.10M | 9.05M | 3.78M | 6.89M |
| Other Financing Activities | -503.11K | 1.31M | 6.64M | -447.88K | -547.38K | |
| Financing Cash Flow | 7.44M | 8.74M | 9.88M | 8.76M | 8.77M | 20.31M |
| Net Cash Flow | -1.53M | 808.28K | 2.38M | -2.02M | -9.12M | 12.07M |
| Free Cash Flow | -8.98M | -7.93M | -7.50M | -10.78M | -17.89M | -8.24M |
| Free Cash Flow Margin | -199.50% | -156.51% | -144.00% | -483.30% | -708.87% | -233.41% |
| Free Cash Flow Per Share | -1.35 | -3.10 | -10.75 | -71.42 | -1,491.24 | |
| Levered Free Cash Flow | -4.15M | -4.42M | -4.96M | -7.42M | -11.19M | -14.66M |
| Unlevered Free Cash Flow | -4.14M | -4.41M | -5.35M | -7.53M | -11.36M | -14.57M |
| Cash Income Tax Paid | 2.50K | 2.50K | 3.20K | 3.20K | 1.60K | 1.60K |
| Change in Working Capital | 2.55M | 1.52M | -851.25K | -947.08K | 5.48M | -1.30M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 8.19M | 3.34M | 10.62M | 3.33M | 4.81M | 113.99M |
| Enterprise Value | 7.71M | 1.73M | 6.53M | 1.90M | 8.95M | 111.81M |
| Last Close Price | 0.42 | 0.92 | 8.14 | 15.90 | 135.00 | 16,920.00 |
| PS Ratio | 1.82 | 0.66 | 2.04 | 1.50 | 1.91 | 32.28 |
| PB Ratio | 1.16 | 3.14 | -5.12 | -1.19 | -13.97 | |
| P/TBV Ratio | 1.04 | 2.86 | ||||
| EV/Sales Ratio | 1.71 | 0.34 | 1.25 | 0.85 | 3.55 | 31.66 |
| Debt / Equity Ratio | -0.18 | 0.11 | 0.09 | -1.31 | -1.10 | -2.11 |
| Net Debt / Equity Ratio | 0.43 | -1.39 | -0.95 | 0.41 | -0.32 | -0.61 |
| Net Debt / EBITDA Ratio | 0.39 | -0.05 | -0.25 | |||
| Net Debt / FCF Ratio | 0.05 | 0.51 | 0.43 | 0.03 | -0.07 | -0.60 |
| Asset Turnover | 1.05 | 0.78 | 1.25 | 0.52 | 0.23 | 0.42 |
| Quick Ratio | 0.27 | 1.04 | 1.64 | 0.37 | 0.36 | 0.77 |
| Current Ratio | 0.70 | 1.59 | 2.42 | 0.69 | 0.56 | 0.95 |
| Return on Equity (ROE) | -1,295.09% | -324.87% | -585.41% | |||
| Return on Assets (ROA) | -185.51% | -98.09% | -101.29% | -155.91% | -135.76% | -148.12% |
| Return on Capital Employed (ROCE) | 1,139.80% | -355.00% | -198.50% | 1,715.20% | 676.80% | 30,894.50% |
| Earnings Yield | -452.07% | -304.50% | -75.19% | -318.25% | -502.55% | -25.51% |
| FCF Yield | -109.62% | -237.30% | -70.63% | -323.25% | -371.89% | -7.23% |
| Buyback Yield / Dilution | -393.27% | -266.55% | -362.24% | -1,158.33% |